Universitätsklinikum Tübingen University
Recent work: Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
Germany
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership